Omuyambi: Traditional Healer Support to Improve HIV Viral Suppression in Rural Uganda

Sponsor
Weill Medical College of Cornell University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05943548
Collaborator
National Institute of Mental Health (NIMH) (NIH), Mbarara University of Science and Technology (Other)
650
1
2
48
13.5

Study Details

Study Description

Brief Summary

This study aims to test a new approach to support people living with Human Immunodeficiency Virus (HIV) in Uganda. Traditional healers (TH) will be trained to provide counselling and testing for HIV, help patients start antiretroviral therapy quickly, and offer guidance on taking medications and staying in HIV care. This support will be given in addition to the regular care provided at clinics. The main goal of the study is to see if this new approach can help more people in rural areas achieve viral suppression.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Omuyambi
  • Behavioral: Control
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
650 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
A parallel arm cluster randomized trial will be used to compare the effectiveness of the intervention to the control.A parallel arm cluster randomized trial will be used to compare the effectiveness of the intervention to the control.
Masking:
None (Open Label)
Masking Description:
Masking is not possible due to the cluster randomized trial design
Primary Purpose:
Supportive Care
Official Title:
Omuyambi: Traditional Healer Support to Improve HIV Viral Suppression in Rural Uganda
Anticipated Study Start Date :
Jul 1, 2023
Anticipated Primary Completion Date :
Jul 1, 2026
Anticipated Study Completion Date :
Jul 1, 2027

Arms and Interventions

Arm Intervention/Treatment
Experimental: Omuyambi Traditional Healer (TH) Intervention

The traditional healer (TH) clusters randomized to the intervention arm will refer consented people living with HIV to a predetermined government-run HIV clinic for the provision of care. The patients that are in this arm will receive, adherence support for PLWH using a TH-tailored curriculum as an adjunct to clinic-based HIV care. These participants will also receive one-on-one counselling to improve self-efficacy, be provided social support, and will work with THs to develop individualized adherence strategies.

Behavioral: Omuyambi
HIV testing, referral, care linkage, and medication adherence support

Placebo Comparator: Control Arm

The traditional healer (TH) clusters randomized to the control arm will refer consented people living with HIV to a predetermined government-run clinic for the provision of care. The patients in this arm will receive no additional linkage or psychosocial support.

Behavioral: Control
HIV Testing and referral

Outcome Measures

Primary Outcome Measures

  1. Viral Load Suppression in People Living with HIV (PLWH) at 12 months [12 months]

    Achievement and maintenance of HIV-1 RNA <200 copies/mL

Secondary Outcome Measures

  1. Linkage to HIV Care [14 Days]

    Number of PLWH linked to HIV care determined by completing one clinic visit within 14 days of study enrollment

  2. Antiretroviral Therapy (ART) Initiation [14 days]

    Number of PLWH initiated on ART determined having (re)initiated ART within 14 days of study enrollment.

  3. Antiretroviral Therapy (ART) Adherence [12 months]

    Number of PLWH adhering to ART determined by hair tenofovir concentration of >0.023 nanograms per milligram.

  4. Retention in Care [12 months]

    Number of PLWH retaining care after 12 months. Defined as a binary outcome as attending the most recent appointment within 90 days of its scheduled date.

  5. Medical Outcomes Study-HIV Health Survey (MOS-HIV) Score at 12 months [12 months]

    This scale evaluated perceived quality of life among people living with HIV. The scale is scored on a 0-100, with higher scores yielding better perceived quality of life.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • age ≥ 18 years old

  • disclose a reactive point-of-care (POC) test on the day of their traditional healer visit

  • Either report no prior HIV diagnosis OR have prior HIV diagnosis and be either ART-naive or have suboptimal ART use (defined by CASE Adherence Index <10)

Exclusion Criteria:
  • Unwilling or unable to participate in study procedures or provide written informed consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mbarara University of Science and Technology Mbarara Uganda

Sponsors and Collaborators

  • Weill Medical College of Cornell University
  • National Institute of Mental Health (NIMH)
  • Mbarara University of Science and Technology

Investigators

  • Principal Investigator: Radhika Sundararajan, MD, Weill Medical College of Cornell University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Weill Medical College of Cornell University
ClinicalTrials.gov Identifier:
NCT05943548
Other Study ID Numbers:
  • 22-09025268
  • 1R01MH132440-01
First Posted:
Jul 13, 2023
Last Update Posted:
Jul 13, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Weill Medical College of Cornell University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 13, 2023